Medicare Enrolled
Dr. Shahram Gholami, MD
Pediatric Urology Physician · San Jose, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gholami from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gholami?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gholami
Dr. Shahram Gholami is a pediatric urology physician in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Gholami performed 12,051 Medicare services across 4,962 unique beneficiaries.
Between the years covered by Open Payments, Dr. Gholami received a total of $140,765 from 71 pharmaceutical and/or device companies across 618 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pediatric urology physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gholami is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 22% volume in CA
$140,765 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,051
Medicare services
Top 22% in CA for pediatric urology physician
4,962
Unique beneficiaries
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~634 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
1,672 | $4 | $13 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
1,594 | $34 | $70 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,357 | $106 | $239 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
1,350 | $11 | $51 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
1,034 | $82 | $140 |
| Nucleic acid test for multiple organisms A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample. |
585 | $69 | $70 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
455 | $77 | $200 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
283 | $111 | $315 |
| Yeast/candida DNA test A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample. |
197 | $34 | $70 |
| Chlamydia trachomatis nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Chlamydia trachomatis bacteria in a sample. |
197 | $34 | $70 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
197 | $34 | $70 |
| Gonorrhea nucleic acid amplification test A laboratory test that uses amplified probe techniques to detect the genetic material of gonorrhea bacteria. This method identifies the presence of the infection by analyzing nucleic acids from the sample. |
197 | $34 | $70 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
197 | $34 | $70 |
| MRSA nucleic acid detection test A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria. |
197 | $34 | $70 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
197 | $34 | $70 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
197 | $34 | $70 |
| Trichomonas vaginalis nucleic acid test A laboratory test that uses an amplified probe technique to detect the genetic material of the Trichomonas vaginalis parasite. This method identifies the presence of the organism responsible for trichomoniasis. |
197 | $34 | $70 |
| Mycoplasma genitalium DNA/RNA test A laboratory test that uses DNA or RNA probes to detect the presence of Mycoplasma genitalium bacteria in a sample. |
187 | $34 | $70 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
171 | $90 | $250 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 135 | $140 | $419 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
131 | $115 | $337 |
| Ultrasound of abdomen and pelvis blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins in the abdomen and pelvis. |
123 | $151 | $546 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
121 | $159 | $319 |
| Complete ultrasound of abdomen and pelvis blood flow This procedure uses sound waves to create images of blood flow in the arteries and veins of the abdomen and pelvis. It evaluates the rate and direction of blood movement within these vessels. |
102 | $281 | $958 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
88 | $9 | $196 |
| Midazolam injection, per 1 mg Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments. |
81 | $0 | $1 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
78 | $965 | $3,000 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
61 | $245 | $512 |
| New patient office visit, complex (60-74 min) | 58 | $185 | $451 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
56 | $147 | $357 |
| Gardnerella vaginalis detection test A laboratory test that uses an amplified probe technique to detect the presence of Gardnerella vaginalis bacteria. |
52 | $34 | $70 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
48 | $380 | $751 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
44 | $34 | $508 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
43 | $130 | $363 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
36 | $77 | $211 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $50 | $100 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
29 | $34 | $88 |
| Laser prostate fragmentation with bleeding control This procedure uses a laser to break up prostate tissue and control bleeding through an endoscope. |
28 | $743 | $2,265 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
25 | $241 | $556 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
25 | $58 | $506 |
| Complicated insertion of bladder tube | 24 | $151 | $295 |
| Injection to cause erection A procedure involving an injection administered to induce an erection. |
22 | $65 | $219 |
| Bladder and urethra clot removal with endoscope A procedure using an endoscope to irrigate and remove multiple blood clots from the bladder and urethra. |
20 | $428 | $904 |
| Phentolamine mesylate injection, up to 5 mg An injection of phentolamine mesylate administered in a dose of up to 5 mg. |
19 | $141 | $190 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
15 | $1,385 | $3,500 |
| Arterial injection of drug or substance A procedure where a medication or other substance is injected directly into an artery. |
15 | $17 | $47 |
| Endoscopic removal of kidney or ureter stone A procedure to remove or manipulate a stone in the kidney or ureter using an endoscope. The endoscope is a thin, lighted tube inserted into the body to visualize and treat the stone. |
14 | $45 | $877 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $324 | $1,250 |
| Radiologist review of ureter or urethra image A radiologist reviews images of the ureter or urethra to evaluate the structures. |
14 | $36 | $285 |
| Ureteral stone crushing with endoscope A procedure to break up a stone in the ureter using an endoscope. The endoscope is inserted to locate and crush the stone. |
13 | $111 | $1,062 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
13 | $50 | $259 |
| Ultrasound of penis artery and vein blood flow An ultrasound exam that uses sound waves to visualize and assess blood flow through the arteries and veins of the penis. |
12 | $110 | $438 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
19.0% medium
80.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$140,765
Total received (2018-2024)
Avg $20,109/year across 7 years
Top 3% in CA for pediatric urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
618
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$118,296 (84.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,418 (8.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,051 (7.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,703
2023
$2,626
2022
$25,117
2021
$30,691
2020
$12,998
2019
$33,162
2018
$15,468
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Arthrex, Inc.
$11,409
Stryker Corporation
$4,988
Medical Device Business Services, Inc.
$1,768
Dendreon Pharmaceuticals LLC
$583
Sumitomo Pharma America, Inc.
$426
Endo Pharmaceuticals Inc.
$196
AstraZeneca Pharmaceuticals LP
$163
Blue Earth Diagnostics Limited
$142
Astellas Pharma US Inc
$129
ACCORD HEALTHCARE, INC.
$111
Teleflex LLC
$103
ABBVIE INC.
$80
IMMUNITYBIO, INC.
$63
PFIZER INC.
$62
Edap Technomed Inc
$60
COLOPLAST CORP
$57
Janssen Biotech, Inc.
$56
Olympus America Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$35
ConvaTec Inc.
$32
Axonics, Inc.
$30
PROCEPT BioRobotics Corporation
$27
US Oncology Corporate, Inc.
$27
Laborie Medical Technologies Corp.
$26
Endo USA, Inc.
$24
INTUITIVE SURGICAL, INC.
$21
Novartis Pharmaceuticals Corporation
$20
Antares Pharma, Inc.
$15
Top 3 companies account for 87.7% of 2024 payments
All-time payments by company (2018-2024) ›
Stryker Corporation
$84,231
Arthrex, Inc.
$17,998
Astellas Pharma US Inc
$8,751
Medical Device Business Services, Inc.
$8,332
Astellas Pharma Global Development
$5,477
Ethicon Inc.
$2,525
PFIZER INC.
$2,420
Dendreon Pharmaceuticals LLC
$1,638
NeoTract Inc.
$1,420
Bayer Healthcare Pharmaceuticals Inc.
$1,011
Janssen Biotech, Inc.
$808
Sumitomo Pharma America, Inc.
$700
Endo Pharmaceuticals Inc.
$592
Amgen Inc.
$479
UROVANT SCIENCES INC
$319
Bayer HealthCare Pharmaceuticals Inc.
$247
180 Medical, Inc.
$226
Antares Pharma, Inc.
$221
AstraZeneca Pharmaceuticals LP
$217
ACCORD HEALTHCARE, INC.
$206
Teleflex LLC
$193
Coloplast Corp
$184
Agiliti Surgical, Inc.
$172
Blue Earth Diagnostics Limited
$170
ABBVIE INC.
$163
MEDIVATION FIELD SOLUTIONS LLC
$128
TOLMAR Pharmaceuticals, Inc.
$117
KARL STORZ Endoscopy-America
$110
Progenics Pharmaceuticals, Inc.
$92
Ethicon US, LLC
$80
Myriad Genetic Laboratories, Inc.
$65
Profound Medical Corp.
$65
IMMUNITYBIO, INC.
$63
Ferring Pharmaceuticals Inc.
$62
Edap Technomed Inc
$60
Hollister Incorporated
$59
COLOPLAST CORP
$57
Zyla Life Sciences
$55
Accord Healthcare, Inc.
$54
Olympus America Inc.
$51
Allergan Inc.
$51
PROCEPT BioRobotics Corporation
$51
Axonics, Inc.
$47
Allergan, Inc.
$46
Duchesnay USA Incorporated
$43
Boston Scientific Corporation
$42
TherapeuticsMD, Inc.
$41
UroGen Pharma, Inc.
$39
Zyla Life Sciences, Inc.
$36
AbbVie, Inc.
$36
AngioDynamics, Inc.
$35
Photocure Inc
$34
Myovant Sciences Inc.
$33
ConvaTec Inc.
$32
Kowa Pharmaceuticals America, Inc.
$29
Tolmar, Inc.
$28
US Oncology Corporate, Inc.
$27
Laborie Medical Technologies Corp.
$26
Foundation Medicine, Inc.
$24
Aytu BioScience, Inc
$24
DAVOL INC.
$24
Endo USA, Inc.
$24
Assertio Therapeutics, Inc.
$24
AbbVie Inc.
$23
UROGEN PHARMA, INC.
$21
INTUITIVE SURGICAL, INC.
$21
Novartis Pharmaceuticals Corporation
$20
EMD Serono, Inc.
$19
Clarus Therapeutics Inc.
$17
Supernus Pharmaceuticals, Inc.
$16
NxThera, Inc.
$12
Top 3 companies account for 78.8% of all-time payments
Associated products mentioned in payments ›
0.30MM · 1188 · 1188 HD AUTOCLAVABLE CAMERA · 1588 · 1588 HD 3 CHIP CAMERA · 1688 · 1688 HD 3 CHIP CAMERA · 24/26 FR. · AIM LAPARASCOPES · ANKTIVA · AQUABEAM SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BIPOLAR · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACANALYSIS CDX · CAMCEVI · CONNECTED OR CART · CONTINENCE CARE · CURE CATHETER · CURE HYDRO · CUTTING LOOP · Certus 140 · Cysview · DRI-LOK DISPOSABLE CANNULAS · Da Vinci Surgical System · EDEX · ELIGARD · ENZALUTAMIDE · ERLEADA · Erleada · FIRMAGON · FLUID SAFE · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENERAL BPH · GENTLECATH · GentleCath · HIP ARTHROSCOPY ACCESS & INSTRUMENTATION SET · ICONIX · IMVEXXY · INFRAVISION IMAGING SYSTEM · IRIS · Infyna Chic · JATENZO · JELMYTO · L10 · LAPAROSCOPIC INSTRUMENTS · LUPRON DEPOT · LYNPARZA · Luja Coude · Lupron Depot · MYRBETRIQ · Myrbetriq · NA · NEW PRODUCT DEVELOPMENT · NOCDURNA · NanoKnife · Natesto · Nubeqa · ORGOVYX · Onli · Optilume BPH Drug Coated Balloon Catheter · Osphena · PERFORMANCE SOLUTIONS · PERISTEEN · PHASIX · PLUVICTO · PNEUMOSURE · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolia · Rezum · SDC3 · SELF-CATH · SPEEDICATH · SPRIX · SPY TECHNOLOGY · SPY-PHI SYSTEM · Seglentis · Sonablate · SpeediCath · TESTOPEL · TITAN · TOVIAZ · Tulsa-Pro · UKIT · UROLIFT · UroLift · UroLift System · VESICARE · VIAGRA · VISTASEAL · VaPro · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZIPSOR · ZORVOLEX · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (84%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for pediatric urology physician in CA.
Geographic Context
Pediatric urology physicians within 10 mi
4
Per 100K population
0.2
County median income
$159,674
Nearest hospital
GOOD SAMARITAN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gholami is a clinical cardiology specialist, with above-average Medicare volume (top 22% in CA), with consulting-driven industry engagement in the top 3% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gholami experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Gholami performed 1,672 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gholami receive payments from pharmaceutical companies?
Yes. Dr. Gholami received a total of $140,765 from 71 companies across 618 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gholami's costs compare to other pediatric urology physicians in San Jose?
Dr. Gholami's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gholami) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pediatric Urology Physicians in San Jose
Browse pediatric urology physicians in San Jose ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Urology Physicians in CA
Pediatric urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Urology Physicians in CA
Which CA pediatric urology physicians receive the most from drug and device companies.
By company
Stryker Corporation Payments to Doctors
See all physicians who received payments from Stryker Corporation.
By company
Arthrex, Inc. Payments to Doctors
See all physicians who received payments from Arthrex, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology